Agenus Inc. News
The Case For a Biotech Snapback
After a challenging year, shares of biotech companies could see rebound following tax loss selling, Bret Jensen says.
Jensen: How to Play Agenus Using Options
Real Money's Bret Jensen outlines simple strategy to use with cancer drug maker.
Bristol-Myers Higher on Progress With Lymphoma-Drug Trial
Bristol-Myers Squibb shares climb after the drugmaker reports progress with a Phase 3 study of a lymphoma treatment.
Buy-the-Dip Candidates: Cramer Likes Abbott Labs, Danaher, and Thermo Fisher
These stocks that fell in the past week could be buy-the-dip opportunities. Recent losers include Okta, Match Group, Procter & Gamble, and more.
Agenus Shares Blast Higher on Deal with Bristol Myers
Bristol Myers Squibb agrees to pay Agenus up to $1.56 billion for the rights to its experimental immuno-cancer treatment.
Las Vegas Strip May Lose a Major Sports Franchise
Sin City usually gets what it wants. That may not happen this time.
Steve Jobs Gets Posthumous Award From President Joe Biden
Jobs was one of 17 people to be awarded the Presidential Medal of Freedom.
Target Has a Surprising New Idea For Cereal Fans
This throwback will excite fans who fondly remember cereals from their childhoods.
TikTok Faces a New Major Threat
The popular short-form social media company is in the hot seat once again in the U.S.